Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT04323735

Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters

Led by Medstar Health Research Institute · Updated on 2025-10-22

182

Participants Needed

1

Research Sites

346 weeks

Total Duration

On this page

Sponsors

M

Medstar Health Research Institute

Lead Sponsor

C

Children's National Research Institute

Collaborating Sponsor

AI-Summary

What this Trial Is About

The objectives of the proposed research among this population are: 1) to define clinically meaningful change (i.e. differentiating states of health and illness) with respect to urinary symptoms, urine inflammation, cultivable bacteria, and the urine ecosystem; and 2) to determine the optimal intravesical Lactobacillus RhamnosusGG (LGG®) dose to be used to reduce urinary symptoms in a future clinical trial.

CONDITIONS

Official Title

Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Neurogenic bladder for at least 6 months
  • Using indwelling catheterization for bladder management
  • Women must be premenopausal and not currently menstruating
  • Living in the community
  • Physical disability
Not Eligible

You will not qualify if you...

  • Use of prophylactic antibiotics
  • Use of intravesical antimicrobials to prevent urinary tract infection
  • Psychological or psychiatric conditions affecting ability to follow instructions
  • Use of oral or intravenous antibiotics within the past 2 weeks
  • Sexual activity within the previous 72 hours
  • Participation in another study that could affect results

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

MedStar National Rehabilitation Hospital

Washington D.C., District of Columbia, United States, 20010

Actively Recruiting

Loading map...

Research Team

A

Amanda K Rounds, PhD

CONTACT

I

Inger H Ljungberg

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here